Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BI-1607 |
Trade Name | |
Synonyms | BI 1607|BI1607 |
Drug Descriptions |
BI-1607 is an antibody that targets Fc gamma receptor IIB, potentially leading to increased inhibition of tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 3423). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BI-1607 | BI-1607 | 0 | 0 |
BI-1607 + Trastuzumab | BI-1607 Trastuzumab | 0 | 1 |